Patents by Inventor Hemanta Koley

Hemanta Koley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enteric fever vaccine based on outer membrane vesicles from two different strains of typhoidal species
    Patent number: 11633466
    Abstract: A novel consortium used as potent vaccine for treating of enteric fever, comprised of isolated Outer Membrane Vesicles (OMVs) taken from two different strains of typhoidal Salmonella species.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: April 25, 2023
    Assignee: INDIAN COUNCIL OF MEDICAL RESEARCH
    Inventors: Hemanta Koley, Debaki Ranjan Howlader, Shanta Dutta
  • Alginate chitosan nanoformulation of OmpA—a protein subunit
    Patent number: 11298415
    Abstract: Provided herein is a Formulation of OmpA including a) OmpA protein as active molecule obtained as a product of OmpA gene inserted in a plasmid comprising a novel set of forward and reverse primer set, and b) Alginate chitosan nanoparticles as vehicle.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: April 12, 2022
    Assignee: Indian Council of Medical Research
    Inventors: Hemanta Koley, Priyadarshini Mukherjee, Dhrubajyoti Nag, Ritam Sinha, Manoj Kumar Chakrabarti
  • ENTERIC FEVER VACCINE BASED ON OUTER MEMBRANE VESICLES FROM TWO DIFFERENT STRAINS OF TYPHOIDAL SALMONELLE SPECIES
    Publication number: 20200384095
    Abstract: A novel consortium used as potent vaccine for treating of enteric fever, comprised of isolated Outer Membrane Vesicles (OMVs) taken from two different strains of typhoidal Salmonella species.
    Type: Application
    Filed: March 21, 2018
    Publication date: December 10, 2020
    Inventors: Hemanta Koley, Debaki Ranjan Howlader, Shanta Dutta
  • Alginate Chitosan Nanoformulation of OmpA - a Shigella Protein Subunit
    Publication number: 20190060436
    Abstract: Provided herein is a Formulation of OmpA including a) OmpA protein as active molecule obtained as a product of OmpA gene inserted in a plasmid comprising a novel set of forward and reverse primer set, and b) Alginate chitosan nanoparticles as vehicle.
    Type: Application
    Filed: April 28, 2017
    Publication date: February 28, 2019
    Inventors: Hemanta Koley, Priyadarshini Mukherjee, Dhrubajyoti Nag, Ritam Sinha, Manoj Kumar Chakrabarti